InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: ADVFN_franknstein post# 20084

Tuesday, 11/17/2015 9:50:27 AM

Tuesday, November 17, 2015 9:50:27 AM

Post# of 118384
I don't recall nearly everyone claiming RGBP was holding back the news, but nearly everyone was expecting FDA approval news because yes, we thought the Sept 25th CRL audited report data would be "forwarded" or compiled and submitted in proper form to the FDA within a couple weeks or so, leaving 30 days after that for news.

No, we didn't expect it to take until Nov 17th to submit the data. But our expectations now remain the same, i.e. that we will hear FDA news within 30 days of data being submitted, so yes, I do expect FDA news, good or bad, but certainly expecting good based on data and PRs released and prior FDA approval for manufacturing and clinical protocol already in place. We have been told the safety data was the last hurdle and we've been told the safety data shows no toxicology concerns, so yes, it is reasonable to expect FDA approval at this point.


That's funny. In the last two months nearly everybody here claimed that RGBP already got FDA approval and holds back the news for good reason / reasons.
But in reality they had nothing submitted.
Why people now think it will be different next time and Mr. Koos will not hold back the news for another 2 months.
To benefit his shareholder ... LOL.